JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heiss, W.-D.
Right arrow Articles by Nutt, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heiss, W.-D.
Right arrow Articles by Nutt, R.
Journal of Nuclear Medicine Vol. 45 No. 11 1811-1815
© 2004 by Society of Nuclear Medicine


Clinical Investigations

Metabolic Rates in Small Brain Nuclei Determined by High-Resolution PET

Wolf-Dieter Heiss, MD1,2, Birgit Habedank, MD1, Johannes Christian Klein, MD1, Karl Herholz, MD2, Klaus Wienhard, PhD1, Mark Lenox3 and Ron Nutt, PhD4

1 Max Planck Institute for Neurological Research, Köln, Germany
2 Department of Neurology, University of Cologne, Cologne, Germany
3 CPS Innovations, Knoxville, Tennessee
4 CTI Molecular Imaging, Knoxville, Tennessee

Identification of small nuclei in the brain by PET has been limited by the spatial resolution of conventional scanners. The new detector technology and advanced signal analysis of a high-resolution research tomograph (HRRT) has improved 3-dimensional spatial resolution to 2.2 mm at sufficient efficiency and permitted the quantification of tracer concentrations in small volumes. Methods: In 9 healthy volunteers, cerebral glucose metabolism was investigated after intravenous injection of 370 MBq of 18F-FDG, and regional cerebral metabolic rates for glucose (rCMRGlc) were determined in various structures of the brain identified on coregistered MR images using stereotactic and topographic anatomic information. Results: rCMRGlc values (in µmol/100 g/min) were higher in the cerebral cortex (33.5 ± 2.98), the basal ganglia (32.6 ± 3.04 in the nucleus caudatus and 40.2 ± 3.50 in the putamen), the thalamus (36.6 ± 4.72), and the cerebellum (29.8 ± 2.20) and were lower in the cerebral white matter (12.3 ± 1.45) than those reported previously with conventional scanners. This resulted in an increased ratio of cortical values to white-matter values. Various nuclei in the basal frontal lobe (21.4 ± 3.19 in the basal forebrain and 32.3 ± 2.39 in the nucleus accumbens), the temporal lobe (22.2 ± 1.74 in the corpus amygdalae), the hippocampus (25.7 ± 2.11), the diencephalon (23.1 ± 3.33 in the corpus geniculatum laterale, 20.2 ± 2.87 in the corpus geniculatum mediale, and 25.2 ± 3.29 in the nucleus subthalamicus), and the brain stem (24.4 ± 2.47 in the colliculus superior, 31.4 ± 3.63 in the colliculus inferior, 31.0 ± 3.10 in the nucleus ruber, and 22.8 ± 2.35 in the substantia nigra) could be identified, and the metabolic rate was assessed in these structures. The effect of improved spatial resolution on quantified metabolic rates could directly be demonstrated in a few cases investigated on scanners of different generations. Conclusion: The improved spatial resolution of the HRRT decreased partial-volume effects in the quantification of metabolic rates in the brain and increased the accuracy of rCMRGlc values in large structures. For the first time, this scanner has permitted the determination of metabolic rates in small nuclei that are involved in various neurodegenerative disorders.

Key Words: high-resolution PET • glucose metabolic rate • small brain nuclei • partial-volume effect


Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8A-9A. [Full Text]  



This article has been cited by other articles:


Home page
RadiologyHome page
H.-P. W. Schlemmer, B. J. Pichler, M. Schmand, Z. Burbar, C. Michel, R. Ladebeck, K. Jattke, D. Townsend, C. Nahmias, P. K. Jacob, et al.
Simultaneous MR/PET Imaging of the Human Brain: Feasibility Study
Radiology, September 1, 2008; 248(3): 1028 - 1035.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. C. Klein, K. Herholz, K. Wienhard, and W.-D. Heiss
Cortical Flattening Applied to High-Resolution 18F-FDG PET
J. Nucl. Med., January 1, 2008; 49(1): 44 - 49.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Leroy, C. Comtat, R. Trebossen, A. Syrota, J.-L. Martinot, and M.-J. Ribeiro
Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT
J. Nucl. Med., April 1, 2007; 48(4): 538 - 546.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Van Laere, B. Nuttin, L. Gabriels, P. Dupont, S. Rasmussen, B. D. Greenberg, and P. Cosyns
Metabolic Imaging of Anterior Capsular Stimulation in Refractory Obsessive-Compulsive Disorder: A Key Role for the Subgenual Anterior Cingulate and Ventral Striatum
J. Nucl. Med., May 1, 2006; 47(5): 740 - 747.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.